These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6248207)

  • 1. Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.
    Matsubara S; Suzuki M; Nakamura M; Edo K; Ishida N
    Cancer Res; 1980 Jul; 40(7):2534-8. PubMed ID: 6248207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired induction of type II interferon in tumor-bearing mice.
    Matsubara S; Suzuki M; Ishida N
    Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a bone-resorptive factor from human cancer ascites fluid.
    Nimberg RB; Humphries DE; Lloyd WS; Badger AM; Cooperband SR; Wells H; Schmid K
    Cancer Res; 1978 Jul; 38(7):1983-9. PubMed ID: 657136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice.
    Lackovic V; Borecký L; Zschiesche W; Fahlbusch B; Schumann I
    Acta Virol; 1980 Jan; 24(1):45-54. PubMed ID: 6155777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
    Cornelius JG; Normann SJ
    J Immunol; 1988 Sep; 141(6):2175-80. PubMed ID: 3139755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14C-arginine-rich basic proteins in ascitic fluid of Ehrlich tumor.
    Farbiszewski R; Zdrodowska J; Kilczewska D
    Neoplasma; 1981; 28(5):617-9. PubMed ID: 7312080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Purification of skin reactive factor (SRF) in mice].
    Fahlbusch B; Gutsche W; Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):93-6. PubMed ID: 135506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonprecipitability of the nucleic factor in the ultracentrifugation of tumor ascitic fluid].
    Belokhvostov AS
    Vopr Onkol; 1984; 30(7):94-6. PubMed ID: 6464407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood ammonia in mice bearing Ehrlich ascites tumors].
    Carrascosa JM; Martínez P; Núñez de Castro I
    Rev Esp Fisiol; 1982; 38 Suppl():195-8. PubMed ID: 7146577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance of ascitic fluid immunosuppressive factor DNA to pancreatic deoxyribonuclease].
    Belokhvostov AS; Zelenkova NK
    Biokhimiia; 1979 Apr; 44(4):711-4. PubMed ID: 435581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular nucleic acid in ascitic experimental tumors].
    Belokhvostov AS; Kozlov AP; Zelenkova NK
    Vopr Onkol; 1976; 22(8):45-9. PubMed ID: 186955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma.
    Isidoro C; Démoz M; De Stefanis D; Baccino FM; Bonelli G
    Invasion Metastasis; 1995; 15(3-4):116-24. PubMed ID: 8621267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The origin of 5 S DNA from tumor ascitic fluid].
    Belokhvostov AS; Tomilin NV
    Eksp Onkol; 1984; 6(4):30-3. PubMed ID: 6499747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the factor of ascites fluid of Erlich tumor].
    Belokhvostov AS; Zelenkova NK; Kalinovskiĭ VP; Mikhalevskaia LA; Perevozchikov AP
    Vopr Onkol; 1976; 22(10):66-72. PubMed ID: 1014496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
    Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
    Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.